DOP2010000261A - Derivados biciclicos heterociclicos o espirobicicicos heterociclicos enlazados , de pirazolo[1,5-a] pirimidinas, procedimientos para su preparacion y usos de los mismos - Google Patents
Derivados biciclicos heterociclicos o espirobicicicos heterociclicos enlazados , de pirazolo[1,5-a] pirimidinas, procedimientos para su preparacion y usos de los mismosInfo
- Publication number
- DOP2010000261A DOP2010000261A DO2010000261A DO2010000261A DOP2010000261A DO P2010000261 A DOP2010000261 A DO P2010000261A DO 2010000261 A DO2010000261 A DO 2010000261A DO 2010000261 A DO2010000261 A DO 2010000261A DO P2010000261 A DOP2010000261 A DO P2010000261A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- heterociclic
- pirazolo
- pyrimidins
- birds
- procedures
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Se describen compuestos de fórmula A: y sales farmacéuticamente aceptables de los mismos, que inhiben selectivamente la actividad Raf quinasa y son útiles para tratar trastornos mediados por Raf quinasas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6784308P | 2008-02-29 | 2008-02-29 | |
US11680908P | 2008-11-21 | 2008-11-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
DOP2010000261A true DOP2010000261A (es) | 2010-09-15 |
Family
ID=40548843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DO2010000261A DOP2010000261A (es) | 2008-02-29 | 2010-08-27 | Derivados biciclicos heterociclicos o espirobicicicos heterociclicos enlazados , de pirazolo[1,5-a] pirimidinas, procedimientos para su preparacion y usos de los mismos |
Country Status (24)
Country | Link |
---|---|
US (1) | US20100029657A1 (es) |
EP (1) | EP2271649A1 (es) |
JP (1) | JP2011513334A (es) |
KR (1) | KR20100123725A (es) |
CN (1) | CN102083835A (es) |
AP (1) | AP2010005363A0 (es) |
AR (1) | AR070728A1 (es) |
AU (1) | AU2009219175A1 (es) |
BR (1) | BRPI0908403A2 (es) |
CA (1) | CA2716499A1 (es) |
CO (1) | CO6321261A2 (es) |
CR (1) | CR11650A (es) |
DO (1) | DOP2010000261A (es) |
EA (1) | EA201001188A1 (es) |
EC (1) | ECSP10010429A (es) |
IL (1) | IL207576A0 (es) |
MA (1) | MA32110B1 (es) |
MX (1) | MX2010009458A (es) |
NI (1) | NI201000143A (es) |
PE (1) | PE20091833A1 (es) |
SV (1) | SV2010003654A (es) |
TW (1) | TW200951134A (es) |
WO (1) | WO2009108838A1 (es) |
ZA (1) | ZA201005603B (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007089031A (ja) | 2005-09-26 | 2007-04-05 | Fuji Xerox Co Ltd | 出力装置 |
DK1976828T3 (en) | 2005-12-29 | 2017-03-06 | Celtaxsys Inc | DIAMINE DERIVATIVES AS INhibitors of Leukotriene A4 HYDROLASE |
US8476295B2 (en) | 2009-12-14 | 2013-07-02 | Inspire | Bridged bicyclic RHO kinase inhibitor compounds, composition and use |
MX2012006994A (es) | 2009-12-18 | 2012-07-03 | Mitsubishi Tanabe Pharma Corp | Agente antiplaquetas novedoso. |
EP2402343A1 (en) * | 2010-06-29 | 2012-01-04 | Basf Se | Pyrazole-fused bicyclic compounds |
US8969363B2 (en) | 2011-07-19 | 2015-03-03 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
AU2012325916A1 (en) * | 2011-10-20 | 2014-05-01 | Glaxosmithkline Llc | Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators |
RU2014120166A (ru) | 2011-10-20 | 2015-11-27 | ГЛЭКСОСМИТКЛАЙН ЭлЭлСи | Замещенные бициклические аза-гетероциклы и их аналоги в качестве модуляторов сиртуина |
US9408885B2 (en) | 2011-12-01 | 2016-08-09 | Vib Vzw | Combinations of therapeutic agents for treating melanoma |
US9573954B2 (en) | 2012-11-16 | 2017-02-21 | University Health Network | Pyrazolopyrimidine compounds |
CA2905340C (en) | 2013-03-12 | 2022-05-31 | Celtaxsys, Inc. | Low dose oral formulations of acebilustat |
EP2968264A4 (en) | 2013-03-14 | 2016-11-02 | Celtaxsys Inc | INHIBITORS OF LEUCOTRIENE A4 HYDROLASE |
KR20150131211A (ko) | 2013-03-14 | 2015-11-24 | 켈탁시스, 인코퍼레이티드 | 류코트라이엔 a4 가수분해효소의 저해제 |
EP2970309A4 (en) | 2013-03-14 | 2016-11-09 | Celtaxsys Inc | INHIBITORS OF LEUCOTRIENE A4 HYDROLASE |
KR102455519B1 (ko) * | 2014-03-27 | 2022-10-14 | 얀센 파마슈티카 엔.브이. | ROS1 저해제로서의 치환된 4,5,6,7-테트라히드로피라졸로[1,5-a]피라진 유도체 및 5,6,7,8-테트라히드로-4H-피라졸로[1,5-a][1,4]디아제핀 유도체 |
CN106132967B (zh) * | 2014-03-27 | 2019-05-28 | 詹森药业有限公司 | 作为ros1抑制剂的化合物 |
AR100448A1 (es) | 2014-05-21 | 2016-10-05 | Bayer Cropscience Ag | 5-(hetero)aril-piridazinonas y su uso como herbicida |
EP3507290A1 (en) | 2016-08-31 | 2019-07-10 | Agios Pharmaceuticals, Inc. | Inhibitors of cellular metabolic processes |
JP7341060B2 (ja) | 2017-02-10 | 2023-09-08 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | Mapk経路の活性化に関連付けられる癌の処置のための方法及び医薬組成物 |
CA3085366A1 (en) | 2017-12-22 | 2019-06-27 | Petra Pharma Corporation | Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors |
JP7416716B2 (ja) | 2017-12-28 | 2024-01-17 | トラクト ファーマシューティカルズ インコーポレイテッド | 円柱上皮幹細胞のための幹細胞培養系およびそれに関連した使用法 |
CA3102077A1 (en) | 2018-05-31 | 2019-12-05 | Sanjeev AHUJA | Method of reducing pulmonary exacerbations in respiratory disease patients |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4178449A (en) * | 1978-04-17 | 1979-12-11 | American Cyanamid Company | Pyrazolo[1,5-a]pyrimidines and imidazo-[1,5-a]pyrimidines |
US4236005A (en) * | 1979-07-02 | 1980-11-25 | American Cyanamid Company | Imidazo[1,5-a]pyrimidines |
US4281000A (en) * | 1979-07-09 | 1981-07-28 | American Cyanamid Company | Substituted pyrazolo (1,5-a)pyrimidines and their use as anxiolytic agents |
US4654347A (en) * | 1983-06-23 | 1987-03-31 | American Cyanamid Company | Aryl and heteroaryl[[7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]methanones |
US4626538A (en) * | 1983-06-23 | 1986-12-02 | American Cyanamid Company | [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines |
US4521422A (en) * | 1983-06-23 | 1985-06-04 | American Cyanamid Company | Aryl and heteroaryl[7-(aryl and heteroaryl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones |
US4900836A (en) * | 1983-06-23 | 1990-02-13 | American Cyanamid Company | (3-amino-1H-pyrazol-4-yl) (aryl)methanones |
US7550470B2 (en) * | 2002-12-11 | 2009-06-23 | Merck & Co. Inc. | Substituted pyrazolo[1,5-A]pyrimidines as tyrosine kinase inhibitors |
US7176210B2 (en) * | 2003-02-10 | 2007-02-13 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
EP1744788A4 (en) * | 2004-03-19 | 2010-08-18 | Penn State Res Found | COMBINATIVE METHODS AND COMPOSITIONS FOR TREATING MELANOMA |
CA2643968A1 (en) * | 2006-03-17 | 2007-09-27 | Wyeth | Pyrazolo[1,5-a]pyrimidine derivatives and methods of use thereof |
-
2009
- 2009-02-26 US US12/393,565 patent/US20100029657A1/en not_active Abandoned
- 2009-02-27 PE PE2009000313A patent/PE20091833A1/es not_active Application Discontinuation
- 2009-02-27 KR KR1020107020750A patent/KR20100123725A/ko not_active Application Discontinuation
- 2009-02-27 MX MX2010009458A patent/MX2010009458A/es not_active Application Discontinuation
- 2009-02-27 CN CN2009801153285A patent/CN102083835A/zh active Pending
- 2009-02-27 EA EA201001188A patent/EA201001188A1/ru unknown
- 2009-02-27 CA CA2716499A patent/CA2716499A1/en not_active Abandoned
- 2009-02-27 AP AP2010005363A patent/AP2010005363A0/en unknown
- 2009-02-27 BR BRPI0908403-7A patent/BRPI0908403A2/pt not_active IP Right Cessation
- 2009-02-27 TW TW098106566A patent/TW200951134A/zh unknown
- 2009-02-27 JP JP2010548895A patent/JP2011513334A/ja not_active Withdrawn
- 2009-02-27 AU AU2009219175A patent/AU2009219175A1/en not_active Abandoned
- 2009-02-27 WO PCT/US2009/035422 patent/WO2009108838A1/en active Application Filing
- 2009-02-27 EP EP09713876A patent/EP2271649A1/en not_active Withdrawn
- 2009-02-27 AR ARP090100723A patent/AR070728A1/es not_active Application Discontinuation
-
2010
- 2010-08-05 ZA ZA2010/05603A patent/ZA201005603B/en unknown
- 2010-08-12 IL IL207576A patent/IL207576A0/en unknown
- 2010-08-24 CO CO10104173A patent/CO6321261A2/es not_active Application Discontinuation
- 2010-08-25 CR CR11650A patent/CR11650A/es not_active Application Discontinuation
- 2010-08-26 MA MA33124A patent/MA32110B1/fr unknown
- 2010-08-27 DO DO2010000261A patent/DOP2010000261A/es unknown
- 2010-08-27 SV SV2010003654A patent/SV2010003654A/es not_active Application Discontinuation
- 2010-08-27 NI NI201000143A patent/NI201000143A/es unknown
- 2010-08-27 EC EC2010010429A patent/ECSP10010429A/es unknown
Also Published As
Publication number | Publication date |
---|---|
ZA201005603B (en) | 2011-05-25 |
KR20100123725A (ko) | 2010-11-24 |
AR070728A1 (es) | 2010-04-28 |
AU2009219175A1 (en) | 2009-09-03 |
CA2716499A1 (en) | 2009-09-03 |
JP2011513334A (ja) | 2011-04-28 |
CN102083835A (zh) | 2011-06-01 |
IL207576A0 (en) | 2010-12-30 |
US20100029657A1 (en) | 2010-02-04 |
WO2009108838A1 (en) | 2009-09-03 |
SV2010003654A (es) | 2011-03-23 |
EA201001188A1 (ru) | 2011-04-29 |
WO2009108838A8 (en) | 2009-11-12 |
ECSP10010429A (es) | 2010-09-30 |
EP2271649A1 (en) | 2011-01-12 |
BRPI0908403A2 (pt) | 2015-08-11 |
CO6321261A2 (es) | 2011-09-20 |
AP2010005363A0 (en) | 2010-08-31 |
CR11650A (es) | 2010-09-14 |
TW200951134A (en) | 2009-12-16 |
PE20091833A1 (es) | 2009-11-22 |
NI201000143A (es) | 2011-03-09 |
MA32110B1 (fr) | 2011-02-01 |
MX2010009458A (es) | 2010-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2010000261A (es) | Derivados biciclicos heterociclicos o espirobicicicos heterociclicos enlazados , de pirazolo[1,5-a] pirimidinas, procedimientos para su preparacion y usos de los mismos | |
ECSP13012611A (es) | Derivados de pirazol-aminopirimidina como moduladores de la lrrk2 | |
UY29781A1 (es) | Compuestos diazaspiro sustituidos, sales farmacéuticamente aceptables, composiciones farmacéuticas que contienen los compuestos o sales, métodos de preparación y usos | |
CO6620050A2 (es) | Derivados de aminopirimidina como moduladores de la lrrk2 | |
ECSP088210A (es) | Bencimidazoles sustituidos y métodos de preparación | |
DOP2009000141A (es) | Derivados de dihidropiridina de utilidad como inhibidores de la proteína quinasa | |
CO6491058A2 (es) | Derivados de oxazina y su uso como inhibidores de bace para el tratamiento de trastornos neurológicos | |
ECSP088121A (es) | Derivados de pirrolo [2,3-b] piridina comoinhibidores de proteina cinasa | |
BRPI0811617A2 (pt) | derivados de primidina e composições como inibidores de c-kit e pdgfr quinase. | |
CO6321136A2 (es) | Derivados de indazol sustituido por axadiazol para uso como agonistas de esfingosina 1 fosfato (s1p) | |
CU20140023A7 (es) | DERIVADOS DE N-(3-(1,2,4-OXADIAZOL-3/5-IL)FENIL)IMIDAZO[1,2-a]PIRIDIN-3-CARBOXAMIDA COMO INHIBIDORES DE LA QUINASA c-Kit | |
NI201000145A (es) | DERIVADOS DE IMIDAZO - [1, 2-b] - PIRIDAZINA PARA EL TRATAMIENTO DE ENFERMEDAD MEDIADA POR CINASA DE TIROSINA C-MET. | |
EA200901488A1 (ru) | Замещенные имидазолопиридазины, как ингибиторы липидкиназы | |
NI201000137A (es) | Pirrolo [2,3-d] piridinas y usos de las mismas como inhibidores de cinasa de tirosina. | |
NO20085257L (no) | Purinonderivater som HM74a-agonister | |
CO6612228A2 (es) | Inhibidores de jak2 y su uso en el tratamiento de enfermedades mieloproliferativas y cancer | |
UY29469A1 (es) | Compuestos sulfoximino-macrocíclicos y sus sales, composiciones farmacéuticas que comprenden dichos compuestos, métodos de preparación y usos de los mismos. | |
CY1111203T1 (el) | 4-ανιλινοκινολινο-3-καρβοξαμιδια ως αναστολεις κινασης csf-1r | |
EA201500182A1 (ru) | 4-МЕТИЛ-2,3,5,9,9b-ПЕНТААЗАЦИКЛОПЕНТА[a]НАФТАЛИНЫ | |
NO20085099L (no) | Puritonderivativer som HM74A agonister | |
ECSP088925A (es) | Nitrilos espirocíclicos como inhibidores de proteasa | |
BRPI0519709A2 (pt) | derivados de tetralina e indano e usos dos mesmos como antagonistas de 5-ht | |
AR080871A1 (es) | Tieno[3,2-b]piridinas sustituidas como inhibidores de la actividad de la proteina tirosina quinasa | |
ECSP088250A (es) | Derivados de pirazol como agentes terapéuticos | |
UY32829A (es) | Derivados de 3-heteroaril-metil-imidazo-[1,2-b]-pirididazin - 6 -ilo |